ERP
LIVE

Serial Number

88221611

Owner

Mononuclear Therapeutics Limited

Attorney

Susan J. Brushaber

First Use Date

Nov 1, 2019

Filing Date

Dec 7, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ERP Trademark

Serial Number: 88221611 • Registration: 6137043

ERP is a trademark filed by Mononuclear Therapeutics Limited on December 7, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Mononuclear Therapeutics Limited (3 trademarks)

Unit 323, Bldg 16W, HK Science Park
Shatin NT , HK

Entity Type: 16

Trademark Details

Filing Date

December 7, 2018

Registration Date

August 25, 2020

First Use Anywhere

November 1, 2019

First Use in Commerce

November 1, 2019

Published for Opposition

October 22, 2019

Goods & Services

Pharmaceutical preparations for medical purposes for blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; plasma for treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; diagnostic and therapeutic preparations for medical or veterinary use, in particular preparations produced using molecular biological, biotechnological and genetic methods; surgical implants grown from stem cells; stem cells for medical purposes; pharmaceutical preparations for stem cell transplantation, therapy and research; pharmaceutical and veterinary preparations for treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; sanitary preparations for medical purposes; blood plasma; reagents for medical purposes; medical diagnostic reagent; biological preparations for medical purposes used in the treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; chemical preparations for pharmaceutical purposes, namely, chemical preparations for blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; diagnostic preparations for medical purposes; pharmaceutical products for the treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 25, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 22, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 22, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 22, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Aug 25, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 23, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 22, 2020 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 2, 2020 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Jul 1, 2020 SUPC
SOU EXTENSION 1 GRANTED
Jul 1, 2020 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 1, 2020 AITU
USE AMENDMENT FILED
Jun 17, 2020 IUAF
SOU EXTENSION 1 FILED
Jun 17, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 17, 2020 EEXT
TEAS STATEMENT OF USE RECEIVED
Jun 17, 2020 EISU
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 29, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 29, 2020 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 17, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 22, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 22, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 2, 2019 NONP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 25, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 25, 2019 REAP
ASSIGNED TO LIE
Sep 18, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 14, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 13, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 12, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 12, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 13, 2019 GNRN
NON-FINAL ACTION E-MAILED
Mar 13, 2019 GNRT
NON-FINAL ACTION WRITTEN
Mar 13, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 31, 2018 NWOS
NEW APPLICATION ENTERED
Dec 11, 2018 NWAP